Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 53, 2021 - Issue 3
Submit an article Journal homepage
272
Views
5
CrossRef citations to date
0
Altmetric
Articles

Pregabalin Misuse: Motives, Pattern, and Knowledge about Its Risks among Patients in Methadone Maintenance Treatment

Einat Pelesa Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel;b Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel;c Sagol School of Neuroscience, Tel-Aviv Tel-Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
View further author information
,
Anat Sasona Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research, Tel-Aviv Sourasky Medical Center, Tel Aviv, IsraelView further author information
,
Shaul Schreibera Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel;b Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel;c Sagol School of Neuroscience, Tel-Aviv Tel-Aviv University, Tel Aviv, Israel;d Department of Psychiatry, Tel-Aviv Sourasky Medical Center, Tel-Aviv, IsraelView further author information
&
Miriam Adelsona Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research, Tel-Aviv Sourasky Medical Center, Tel Aviv, IsraelView further author information
Pages 238-246 | Received 13 Jul 2020, Accepted 28 Oct 2020, Published online: 24 Dec 2020

References

  • Abrahamsson, T., J. Berge, A. Öjehagen, and A. Håkansson. 2017. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. Drug and Alcohol Dependence 174:58–64. doi:10.1016/j.drugalcdep.2017.01.013.
  • Adelson, M., S. Linzy, and E. Peles. 2018. Characteristics and outcome of male and female methadone maintenance patients: MMT in Tel Aviv and Las Vegas. Substance Use & Misuse 53 (2):230–38. doi:10.1080/10826084.2017.1298619.
  • Bockbrader, H. N., D. Wesche, R. Miller, S. Chapel, N. Janiczek, and P. Burger. 2010. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clinical Pharmacokinetics 49 (10):661–69. doi:10.2165/11536200-000000000-00000.
  • Bonnet, U., E. L. Richter, K. Isbruch, and N. Scherbaum. 2018. On the addictive power of gabapentinoids: A mini-review, Psychiatria Danubina, 30: 142–49
  • Cairns, R., Schaffer, A.L., Ryan, N., Pearson, S.A., Buckley, N.A. 2019. Rising pregabalin use and misuse in Australia: Trends in utilization and intentional poisonings. Addiction 114:1026–34.  Epub 2018 Sep 5. doi:10.1111/add.14412.
  • Daly, C., E. Griffin, D. M. Ashcroft, R. T. Webb, I. J. Perry, and E. Arensman. 2018. Intentional drug overdose involving Pregabalin and Gabapentin: Findings from the national self-harm registry Ireland, 2007-2015. Clinical Drug Investigation 38 (4):373–80. doi:10.1007/s40261-017-0616-y.
  • Dworkin, R. H., and P. Kirkpatrick. 2005. Pregabalin. Nature Reviews Drug Discovery 4 (6):455–56. doi:10.1038/nrd1756.
  • Eyler, E. C. 2013. Chronic and acute pain and pain management for patients in methadone maintenance treatment. The American Journal on Addictions 22 (1):75–83. doi:10.1111/j.1521-0391.2013.00308.x.
  • Goodman, C. W., and A. S. Brett. 2017. Gabapentin and Pregabalin for pain - is increased prescribing a cause for concern? New England Journal of Medicine 377 (5):411–14. doi:10.1056/NEJMp1704633.
  • Hawks, R. L. 1986. Analytical methodology. NIDA Research Monograph 73:30–42.
  • Ianni, F., K. Aroni, A. Gili, R. Sardella, M. Bacci, M. Lancia, B. Natalini, and C. Gambelunghe. 2018. GC-MS/MS detects potential pregabalin abuse in susceptible subjects’ hair. Drug Testing and Analysis 10 (6):968–76. doi:10.1002/dta.2347.
  • Mattick, R. P., C. Breen, J. Kimber, and M. Davoli. 2014. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2:CD002207.
  • Peles, E., S. Schreiber, and M. Adelson. 2008. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT). European Neuropsychopharmacology 18 (3):188–93. doi:10.1016/j.euroneuro.2007.10.001.
  • Peles, E., S. Schreiber, S. Linzy, Y. Domani, and M. Adelson. 2015. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics. Journal of Substance Abuse Treatment 54 (54):44–49. doi:10.1016/j.jsat.2014.12.010.
  • Peles, E., S. Schreiber, A. Sason, and M. Adelson. 2018. Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center. Drug and Alcohol Dependence 185:112–19. doi:10.1016/j.drugalcdep.2017.11.034.
  • Sason, A., M. Adelson, S. Schreiber, and E. Peles. 2018. Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors. Drug and Alcohol Dependence 189:8–11. doi:10.1016/j.drugalcdep.2018.04.025.
  • Schifano, F. 2014. Misuse and abuse of pregabalin and gabapentin: Cause for concern? CNS Drugs 28 (6):491–96. doi:10.1007/s40263-014-0164-4.
  • Schjerning, O., M. Rosenzweig, A. Pottegård, P. Damkier, and J. Nielsen. 2016. Abuse potential of pregabalin: A systematic review. CNS Drugs 30 (1):9–25. doi:10.1007/s40263-015-0303-6.
  • Spence, D. 2013. Bad medicine: Gabapentin and pregabalin. BMJ 347 (nov08 3):f6747. doi:10.1136/bmj.f6747.
  • Wettermark, B., L. Brandt, H. Kieler, and R. Bodén. 2014. Pregabalin is increasingly prescribed for neuropathic pain, generalized anxiety disorder and epilepsy but many patients discontinue treatment. International Journal of Clinical Practice 68 (1):104–10. doi:10.1111/ijcp.12182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.